Delivery Order SPE2DB22D1017-SPE2DB24FF5TF
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The $1,526.98 delivery order has a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract with DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564147460 - TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award, valued at $7,194.39, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The delivery order, valued at $2,369.21, has an ultimate completion date of April 9, 2024. This contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The contract has a potential value of $1,310.98 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. The contract is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trelegy Ellipta 100-62.5-25 60S pharmaceutical product. The award, valued at $9,144.90, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is a child of a larger indefinite delivery contract (IDC) with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 200-62.5-25 60S medication. The $26,055.97 contract has a performance period through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $12,193.62 firm fixed price contract has an ultimate completion date of April 23, 2024 and is not set aside for any small business designation. Amerisourcebergen is fulfilling this order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The $7,259.43 contract has an ultimate completion date of March 29, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office in Conshohocken, Pennsylvania, serves as the prime contractor for this award, which is part...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5TFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $6,322.28 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.
Generated 7/10/24, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 4/10/24 |